Episode
Animal Health’s 2025 Takeaways & 2026 Outlook
- Podcast
- Animal Health Insider
- Published
- Feb 4, 2026
- Duration seconds
- 2406
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/animal-health-insider-7620952/episodes/animal-health-s-2025-takeaways-2026-outlook/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/animal-health-insider-7620952/animal-health-s-2025-takeaways-2026-outlook.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
What’s next for animal health in 2026—and what did the world’s largest veterinary conference reveal that the industry can’t afford to ignore? Insiders Julie Lawless, Dr. Beatrice Vos, and Joseph Harvey break down the biggest takeaways from VMX 2026, revisit defining 2025 industry highlights, and share bold predictions on what’s ahead in 2026. Discussion points include everything from growth, competition, and regulatory shifts to M&A, IPOs, and regenerative medicine. #AnimalHealth #Veterinary #VMX2026 About Animal Health Insider Animal Health Insider takes you behind the scenes of the Animal Health industry. Each episode starts with conversation from the “Insiders”, followed by in-depth conversations with the leaders and disruptors shaping what’s next. If you work in #AnimalHealth, #Veterinary, #Biotech, #Agtech, #Sustainability, #Investment, or #PublicPolicy, subscribe for a sharper context and real insight from the people on the inside of the industry. 🌐 Learn more at https://www.lawlesscomms.com/podcast/ LawlessComms Ready to build industry influence and engage employees through strategic communications made for Animal Health? We’re here to help! 🌐 https://www.lawlesscomms.com/ LinkedIn: LinkedIn: https://www.linkedin.com/in/julielawless Stonehaven Transactions With decades of commercial and legal experience in M&A and other transactions in the animal health sector, Stonehaven Transactions guides small and large life science companies and investors through buy-side or sell-side transactions, license deals and commercial collaborations, ensuring value maximization, a seamless process, optimized synergies, and long-term growth. 🌐 https://sc.group/transactions/ LinkedIn: https://www.linkedin.com/in/dr-beatrice-vos-4184201/ S&P Global Animal Health Beyond the…